Neurodegeneration markers are molecular indicators of central nervous system (CNS) pathology in disorders such as Alzheimer’s and Parkinson’s disease. Detected in CSF or blood, these markers enable early diagnosis, disease staging, and therapeutic monitoring. Their measurement facilitates greater mechanistic insight into neurodegenerative disorder progression while also contributing to clinical management.